These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


703 related items for PubMed ID: 1396957

  • 1. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
    Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A.
    Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
    [Abstract] [Full Text] [Related]

  • 2. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA, Fernández MA, Fresno M.
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [Abstract] [Full Text] [Related]

  • 3. Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism.
    Vincendeau P, Daulouède S.
    J Immunol; 1991 Jun 15; 146(12):4338-43. PubMed ID: 1904079
    [Abstract] [Full Text] [Related]

  • 4. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
    Green SJ, Meltzer MS, Hibbs JB, Nacy CA.
    J Immunol; 1990 Jan 01; 144(1):278-83. PubMed ID: 2104889
    [Abstract] [Full Text] [Related]

  • 5. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.
    Oswald IP, Gazzinelli RT, Sher A, James SL.
    J Immunol; 1992 Jun 01; 148(11):3578-82. PubMed ID: 1588047
    [Abstract] [Full Text] [Related]

  • 6. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
    Khan IA, Matsuura T, Fonseka S, Kasper LH.
    J Immunol; 1996 Jan 15; 156(2):636-43. PubMed ID: 8543815
    [Abstract] [Full Text] [Related]

  • 7. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
    Hatzigeorgiou DE, He S, Sobel J, Grabstein KH, Hafner A, Ho JL.
    J Immunol; 1993 Oct 01; 151(7):3682-92. PubMed ID: 8397259
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.
    Anthony LS, Morrissey PJ, Nano FE.
    J Immunol; 1992 Mar 15; 148(6):1829-34. PubMed ID: 1541823
    [Abstract] [Full Text] [Related]

  • 9. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia.
    Feder LS, Laskin DL.
    J Leukoc Biol; 1994 Apr 15; 55(4):507-13. PubMed ID: 8145021
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans.
    Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F.
    Eur J Immunol; 1993 May 15; 23(5):1034-8. PubMed ID: 8477799
    [Abstract] [Full Text] [Related]

  • 11. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
    Nelson BJ, Ralph P, Green SJ, Nacy CA.
    J Immunol; 1991 Mar 15; 146(6):1849-57. PubMed ID: 1900875
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY, Seguin R, Keller K, Chadee K.
    Immunology; 1995 Jul 15; 85(3):400-7. PubMed ID: 7558128
    [Abstract] [Full Text] [Related]

  • 13. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
    Gazzinelli RT, Oswald IP, James SL, Sher A.
    J Immunol; 1992 Mar 15; 148(6):1792-6. PubMed ID: 1541819
    [Abstract] [Full Text] [Related]

  • 14. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 15. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.
    Adams LB, Hibbs JB, Taintor RR, Krahenbuhl JL.
    J Immunol; 1990 Apr 01; 144(7):2725-9. PubMed ID: 2319133
    [Abstract] [Full Text] [Related]

  • 16. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
    Langermans JA, Van der Hulst ME, Nibbering PH, Hiemstra PS, Fransen L, Van Furth R.
    J Immunol; 1992 Jan 15; 148(2):568-74. PubMed ID: 1729374
    [Abstract] [Full Text] [Related]

  • 17. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    Ding AH, Nathan CF, Stuehr DJ.
    J Immunol; 1988 Oct 01; 141(7):2407-12. PubMed ID: 3139757
    [Abstract] [Full Text] [Related]

  • 18. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine.
    Lin JY, Chadee K.
    J Immunol; 1992 Jun 15; 148(12):3999-4005. PubMed ID: 1318338
    [Abstract] [Full Text] [Related]

  • 19. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA, Coffman RL.
    J Immunol; 1995 Oct 15; 155(8):3955-63. PubMed ID: 7561103
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
    Cox GW, Melillo G, Chattopadhyay U, Mullet D, Fertel RH, Varesio L.
    J Immunol; 1992 Nov 15; 149(10):3290-6. PubMed ID: 1431106
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.